股票 › QURE
uniQure基因治疗 QURE
美股市值排名 #2937
$21.70 +$0.69 (+3.28%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $22.00 +1.38%
开盘$21.25
昨收$21.01
当日区间$21.10 – $21.93
成交量1.17M
市值$1.52B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$5.84M+11.0% YoY
营业利润-$44.68M-4.2% YoY
净利润-$81.06M-114.9% YoY
摊薄每股收益-$1.22-76.8% YoY
自由现金流-$29.05M+27.7% YoY
经营现金流-$28.58M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率92.5%
营业利润率-1,020.8%
净利率-1,350.7%
净资产收益率-157.6%
资产收益率-32.1%
投入资本回报率-99.0%
流动比率10.01
负债/资产比率67.1%
现金及投资$810.34M
总负债$59.84M
净现金（净负债）$750.49M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $5.84M | $3.56M | $16.10M | $5.57M | $3.70M |
| 营业总收入 | $5.84M | $3.56M | $16.10M | $5.57M | $3.70M |
| 营业成本 | $350,000.00 | $219,000.00 | $1.69M | $435,000.00 | $398,000.00 |
| 毛利润 | $5.49M | $3.34M | $14.41M | $5.13M | $3.30M |
| 营业费用 | $50.17M | $47.61M | $202.24M | $56.63M | $52.79M |
| 销售及管理费用 | $17.37M | $20.07M | $65.34M | $21.49M | $19.44M |
| 研发费用 | $33.96M | $29.18M | $140.67M | $34.78M | $34.37M |
| 其他营业费用 | -$1.16M | -$1.63M | -$5.68M | -$1.56M | -$1.01M |
| 营业利润 | -$44.68M | -$44.27M | -$187.83M | -$51.49M | -$49.49M |
| 非经营性利息净收入（支出） | -$9.32M | -$8.80M | -$45.03M | -$7.26M | -$14.72M |
| 非经营性利息收入 | $5.05M | $5.23M | $16.97M | $5.81M | $3.50M |
| 非经营性利息支出 | $14.37M | $14.03M | $61.99M | $14.57M | $16.72M |
| 其他收入（支出） | -$25.23M | $24,000.00 | $39.51M | $17.75M | -$7.70M |
| 证券出售收益 | -$1.73M | -$2.29M | $26.13M | $6.47M | -$6.15M |
| 其他非经营性收入（支出） | -$23.50M | $2.32M | $7.38M | $11.28M | -$1.55M |
| 税前利润 | -$79.22M | -$53.05M | -$193.34M | -$41.00M | -$71.90M |
| 税费 | $1.84M | $488,000.00 | $5.63M | -$3.92M | $8.63M |
| 净利润 | -$81.06M | -$53.54M | -$198.97M | -$37.09M | -$80.53M |
| 持续经营利润 | -$81.06M | -$53.54M | -$198.97M | -$37.09M | -$80.53M |
| 归属母公司净利润 | -$81.06M | -$53.54M | -$198.97M | -$37.09M | -$80.53M |
| 归属普通股股东净利润 | -$81.06M | -$53.54M | -$198.97M | -$37.09M | -$80.53M |
| 基本每股收益 | -$1.22 | -$0.85 | -$3.46 | -$0.56 | -$1.38 |
| 摊薄每股收益 | -$1.22 | -$0.85 | -$3.46 | -$0.56 | -$1.38 |
| -管理费用 | – | – | $65.34M | – | – |
| 折旧、摊销与折耗 | – | – | $1.91M | – | – |
| -折旧与摊销 | – | – | $1.91M | – | – |
| 特殊收益（费用） | – | – | $6.00M | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $0.00 | – | – |
| -业务出售收益 | – | – | $0.00 | $0.00 | $0.00 |
| -固定资产出售收益 | – | – | $6.00M | $0.00 | – |
| 其他财务成本合计 | – | – | – | – | $1.50M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $985.10M | $778.71M | $824.91M | $824.91M | $888.38M |
| 流动资产合计 | $834.27M | $615.74M | $655.99M | $655.99M | $716.19M |
| 现金及现金等价物与短期投资 | $810.34M | $586.55M | $622.54M | $622.54M | $694.25M |
| -现金及现金等价物 | $413.03M | $139.99M | $80.24M | $80.24M | $597.06M |
| -短期投资 | $397.31M | $446.56M | $542.30M | $542.30M | $97.19M |
| 应收款 | $5.78M | $3.56M | $5.86M | $5.86M | $3.88M |
| -应收账款 | $5.78M | $3.56M | $5.86M | $5.86M | $3.88M |
| 预付资产 | $10.25M | $16.59M | $20.51M | $20.51M | $10.33M |
| 其他流动资产 | $7.91M | $9.04M | $7.08M | $7.08M | $7.74M |
| 非流动资产合计 | $150.83M | $162.96M | $168.92M | $168.92M | $172.19M |
| 固定资产净值 | $22.98M | $24.28M | $26.33M | $26.33M | $28.48M |
| -固定资产原值 | $22.98M | $24.28M | $70.06M | $70.06M | $71.98M |
| 投资及预付款 | $15.14M | $15.28M | $30.24M | $30.24M | $30.00M |
| 一年以上应收票据 | $15.12M | $14.87M | – | – | – |
| 商誉及其他无形资产 | $86.69M | $94.80M | $98.15M | $98.15M | $99.47M |
| -商誉 | $24.59M | $24.81M | $25.36M | $25.36M | $25.33M |
| -其他无形资产 | $62.10M | $69.99M | $72.79M | $72.79M | $74.14M |
| 一年以上递延资产 | $6.36M | $8.19M | $8.65M | $8.65M | $8.77M |
| 其他非流动资产 | $4.54M | $5.54M | $5.56M | $5.56M | $5.47M |
| 负债合计 | $661.05M | $629.36M | $626.01M | $626.01M | $659.64M |
| 流动负债合计 | $83.35M | $59.20M | $62.92M | $62.92M | $100.63M |
| 应付款 | $4.98M | $4.40M | $5.17M | $5.17M | $14.05M |
| -应付账款 | $4.98M | $4.40M | $5.17M | $5.17M | $6.23M |
| 一年内应计费用 | $24.68M | $23.49M | $20.49M | $20.49M | $16.94M |
| 短期债务及融资租赁负债 | $2.99M | $2.99M | $3.86M | $3.86M | $3.91M |
| -一年内到期融资租赁负债 | $2.99M | $2.99M | $3.86M | $3.86M | $3.91M |
| 其他流动负债 | $34.04M | $18.19M | $23.46M | $23.46M | $39.20M |
| 非流动负债合计 | $577.71M | $570.17M | $563.09M | $563.09M | $559.00M |
| 长期债务及融资租赁负债 | $59.84M | $60.33M | $59.53M | $59.53M | $62.24M |
| -长期债务 | $50.15M | $49.94M | $49.70M | $49.70M | $51.88M |
| -长期融资租赁负债 | $9.70M | $10.39M | $9.83M | $9.83M | $10.36M |
| 一年以上递延负债 | $7.73M | $7.80M | $7.97M | $7.97M | $7.96M |
| 其他非流动负债 | $510.14M | $502.04M | $495.59M | $495.59M | $488.81M |
| 股东权益合计 | $324.05M | $149.34M | $198.90M | $198.90M | $228.75M |
| 股东权益 | $324.05M | $149.34M | $198.90M | $198.90M | $228.75M |
| 股本 | $4.09M | $3.73M | $3.69M | $3.69M | $3.68M |
| -普通股 | $4.09M | $3.73M | $3.69M | $3.69M | $3.68M |
| 资本公积 | $1.84B | $1.59B | $1.58B | $1.58B | $1.58B |
| 留存收益 | -$1.46B | -$1.38B | -$1.33B | -$1.33B | -$1.29B |
| 不影响留存收益的损益 | -$58.25M | -$59.89M | -$58.22M | -$58.22M | -$58.75M |
| -累计折旧 | – | – | -$43.74M | -$43.74M | -$43.50M |
| -可供出售证券 | – | – | – | – | $15.60M |
| -持有至到期证券 | – | – | – | – | $14.40M |
| -应付税款合计 | – | – | – | – | $7.82M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$28.58M | -$38.24M | -$177.96M | -$77.57M | -$16.40M |
| 持续经营经营活动现金流净额 | -$28.58M | -$38.24M | -$177.96M | -$77.57M | -$16.40M |
| 持续经营净利润 | -$81.06M | -$53.54M | -$198.97M | -$37.09M | -$80.53M |
| 持续经营损益 | $22.12M | -$1.59M | -$35.42M | -$16.61M | $6.35M |
| 折旧、折耗与摊销 | $4.91M | $2.96M | $14.76M | $2.97M | $3.63M |
| 递延税款 | $1.87M | $458,000.00 | $1.59M | -$391,000.00 | $1.06M |
| 其他非现金项目 | $9.28M | $5.59M | $39.66M | $8.17M | $11.04M |
| 营运资金变动 | $12.86M | $7.12M | -$6.79M | -$34.91M | $40.45M |
| -应收款变动 | $5.07M | $3.78M | -$8.60M | -$11.48M | $9.64M |
| -应付账款及应计费用变动 | $7.79M | $3.34M | $1.81M | -$23.43M | $30.81M |
| 投资活动现金流净额 | $53.26M | $98.56M | -$321.62M | -$441.37M | $26.58M |
| 持续经营投资活动现金流净额 | $53.26M | $98.56M | -$321.62M | -$441.37M | $26.58M |
| 固定资产购置及出售净额 | -$472,000.00 | -$140,000.00 | -$439,000.00 | -$119,000.00 | $66,000.00 |
| 投资购置及出售净额 | $53.73M | $98.70M | -$321.18M | -$441.25M | $26.51M |
| 筹资活动现金流 | $249.12M | $550,000.00 | $415.40M | $2.45M | $332.24M |
| 持续经营筹资活动现金流净额 | $249.12M | $550,000.00 | $415.40M | $2.45M | $332.24M |
| 普通股发行净额 | $249.12M | $550,000.00 | $391.90M | $2.45M | $308.74M |
| 期末现金余额 | $414.56M | $141.54M | $81.80M | $81.80M | $598.55M |
| 现金净变动 | $273.80M | $60.87M | -$84.18M | -$516.49M | $342.42M |
| 期初现金余额 | $141.54M | $81.80M | $160.33M | $598.55M | $255.27M |
| 汇率变动影响 | -$774,000.00 | -$1.13M | $5.66M | -$257,000.00 | $862,000.00 |
| 自由现金流 | -$29.05M | -$38.38M | -$178.40M | -$77.69M | -$16.33M |
| -存货变动 | – | – | $0.00 | $0.00 | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 股票期权行使所得 | – | – | $23.50M | $0.00 | – |
暂无评论——快来第一个聊聊 QURE。
登录后参与讨论。